ArticlePloS one2006

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Sarah L Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.